Revisions of 'Pancreatic cystosis'

• Revision 5 - major - created about 1 year ago by Ryan Thibodeau ◉ - view changeset
  Date: 2023-12-28 20:23:40 UTC Disclosures:

  At the time the revision was created Ryan Thibodeau had no financial relationships to ineligible companies to disclose.

  View Ryan Thibodeau's current disclosures Reviewed by: Henry Knipe
• Revision 4 - major - created over 1 year ago by Arlene Campos ◉ - view changeset
  Date: 2023-11-16 03:44:37 UTC Disclosures:

  At the time the revision was created Arlene Campos had no financial relationships to ineligible companies to disclose.

  View Arlene Campos's current disclosures Reviewed by: Ryan Thibodeau
• Revision 3 - major - created over 1 year ago by Fergus O'Herlihy - view changeset
  Date: 2023-11-15 11:58:54 UTC Disclosures:

  At the time the revision was created Fergus O'Herlihy had no financial relationships to ineligible companies to disclose.

  View Fergus O'Herlihy's current disclosures Reviewed by: Ryan Thibodeau
• Revision 2 - major - created over 1 year ago by Henry Knipe ◉ - view changeset
  Date: 2023-11-14 18:49:45 UTC Disclosures:

  At the time the revision was created Henry Knipe had the following disclosures:

  • Integral Diagnostics, Shareholder (ongoing)
  • Micro-X Ltd, Shareholder (ongoing)

  These were assessed during peer review and were determined to not be relevant to the changes that were made.

  View Henry Knipe's current disclosures Reviewed by: Ryan Thibodeau
• Revision 1 - major - created over 1 year ago by Fergus O'Herlihy - view changeset
  Date: 2023-11-13 20:03:31 UTC Disclosures:

  At the time the revision was created Fergus O'Herlihy had no financial relationships to ineligible companies to disclose.

  View Fergus O'Herlihy's current disclosures Reviewed by: Ryan Thibodeau

Unfortunately some older revisions may not be able to be viewed or restored.